Over-The-Counter (OTC) Medication Sales Flag in 2013

Published in CSP Daily News

Pain Relievers    
Remedy typeC-store sales ($ millions)PCYAUnit sales (millions)PCYA
Internal analgesic tablets$327.1-1.8%159.9-5.8%
Internal analgesic liquids$5.829.5%0.928.7%
Feminine pain relievers$5.5-0.9%1.88.0%
Total internal analgesics (including segments not shown)$338.5-1.4%162.5-5.5%
Cold/Allergy/Sinus    
Tablets/packets$117.4-4.7%42.8-3.6%
Liquids$29.44.3%3.7-1.3%
Cough Remedies    
Cough drops$98.43.5%67.61.0%
Cough syrups$6.2-6.9%1.0-7.0%
Gastrointestinal    
Antacid tablets$77.0-1.7%51.2-5.0%
Gastrointestinal liquids$20.3-6.9%4.7-11.4%
Stomach remedy tablets$13.414.8%5.512.0%
Antacid/analgesic combo$9.7-7.9%5.0-6.7%
Diarrhea tablets$6.5-24.1%3.2-8.8%

Source: IRI

IRI

Click here for more yearend healthcare/general merchandise sales data

C-store sales of over-the-counter (OTC) medication flagged in 2013, with even the largest segment—analgesics—seeing declines. Dollar sales of analgesics fell by 1.4% and unit sales fell 5.5%, according to IRI. Cold, allergy and sinus tablets saw smaller declines than in 2012 but still gave up nearly 5% ofdollar sales and nearly 4% in units. Gastrointestinal-remedy dollars were down by 2% and units fell more than 4%.

Keywords: 
HBC, over the counter